Atea plunges after COVID-19 treatment fails to help patients in study

Go back to Atea plunges after COVID-19 treatment fails to help patients in study
(NASDAQ: AVIR) Delayed: 4.78 +0.13 (2.80%)
Previous Close $4.65    52 Week High $2.00 
Open $4.68    52 Week Low $1.15 
Day High $4.79    P/E N/A 
Day Low $4.63    EPS $0.00 
Volume 472,559